How Flu-like Syndromes Contribute to Termination of Weekly Rifapentine-Based TB Preventive Therapy Is Still Poorly Predictable

Clin Infect Dis. 2022 Nov 14;75(10):1865-1866. doi: 10.1093/cid/ciac573.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Humans
  • Isoniazid*
  • Rifampin* / therapeutic use
  • Syndrome

Substances

  • rifapentine
  • Rifampin
  • Isoniazid